International Journal of Scientific Research in Dental and Medical Sciences

International Journal of Scientific Research in Dental and Medical Sciences

Histopathological Spectrum of Hepatic Lesions in Liver Biopsy and Resection Specimens: A Retrospective Study

Document Type : Original Article

Authors
Department of Pathology, Government Kallakuirchi Medical College, Tamilnadu, India
Abstract
Background and aim: Liver diseases include a broad spectrum of non-neoplastic and neoplastic conditions and remain a significant cause of morbidity and mortality worldwide. Histopathological examination is the gold standard for diagnosing many hepatic disorders and plays a crucial role in patient management. This study aimed to evaluate the demographic characteristics and histomorphological spectrum of hepatic lesions diagnosed over two years at a tertiary care centre.
Materials and methods: This retrospective descriptive study included 110 liver biopsy and resection specimens examined in the Department of Pathology at Government Stanley Medical College over 2 years. Routine histopathological evaluation was performed using Hematoxylin and Eosin staining, with immunohistochemistry applied when required. Demographic data, specimen types, and histopathological findings were analyzed.
Results: Of the 110 cases, 53 were biopsies, and 57 were resection specimens. Among biopsy specimens, 32% were non-neoplastic, and 68% were malignant. In resection specimens, 32% were non-neoplastic, 18% were benign neoplasms, and 51% were malignant. A marked male predominance was observed in both groups. Metastatic carcinoma was the most common malignant lesion in biopsy specimens, whereas hepatocellular carcinoma was the predominant malignant tumour in resection specimens. Hydatid cyst was the most frequent non-neoplastic lesion among resected specimens.
Conclusions: Hepatic lesions exhibit a wide histopathological spectrum, with malignant neoplasms comprising the majority of cases. Histopathological evaluation remains essential for accurate diagnosis, appropriate clinical management, and early detection of serious liver diseases, thereby contributing significantly to improved patient outcomes.
Keywords
Subjects

[1] Michalopoulos GK, Bhushan B. Liver regeneration: biological and pathological mechanisms and implications. Nature reviews Gastroenterology & hepatology. 2021;18(1):40-55. https://doi.org/10.1038/s41575-020-0342-4.
[2] Devarbhavi H, Asrani SK, Arab JP, Nartey YA, Pose E, Kamath PS. Global burden of liver disease: 2023 update. Journal of hepatology. 2023;79(2):516-37. https://doi.org/10.1016/j.jhep.2023.03.017.
[3] Marrero JA, Kulik LM, Sirlin CB, Zhu AX, Finn RS, Abecassis MM, et al. Diagnosis, S taging, and M anagement of H epatocellular C arcinoma: 2018 P ractice G uidance by the A merican A ssociation for the S tudy of L iver D iseases. Hepatology. 2018;68(2):723-50.
[4] Yuze Y, Mingda W, Lanqing Y, Xinfei X, Ping Z, Feng S, et al. Progress in the update of 2024 European Association for the Study of the Liver clinical practice guidelines for management of hepatocellular carcinoma. Chinese Journal of Digestive Surgery. 2025;24(2):198-205. https://dx.doi.org/10.3760/cma.j.cn115610-20241224-00580.
[5] Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: a cancer journal for clinicians. 2021;71(3):209-49. https://doi.org/10.3322/caac.21660.
[6] Patel V, Kothari S, Dayal A, Patel N, Akruwala S. Evaluation of histopathological spectrum of hepatic lesions in liver biopsies in a tertiary care hospital. Panacea journal of medical sciences Учредители: IP Innovative Publication. 2022;12(3):690-5.
[7] International Agency for Research on Cancer, editor. WHO classification of tumours of the digestive system. International agency for research on cancer; 2019.
[8] Shetty JK, Prasad HL, Hidangmayum A. The Spectrum of Histopathological Lesions Presenting as a Hepatic Nodule and Their Relationship With Serum Alpha-Fetoprotein Level. Journal of Health and Allied Sciences NU. 2026. https://doi.org/10.25259/JHASNU_242_2025.
[9] Ilyas SI, Khan SA, Hallemeier CL, Kelley RK, Gores GJ. Cholangiocarcinoma—evolving concepts and therapeutic strategies. Nature reviews Clinical oncology. 2018;15(2):95-111. https://doi.org/10.1038/nrclinonc.2017.157.
[10] Costa AC, Santa-Cruz F, Guimarães H, Paz AR, Costa EA, Figueiredo JL, Ferraz ÁA. Primary hepatic neuroendocrine tumor: A case report and literature review. International Journal of Surgery Case Reports. 2020;72:1-4. https://doi.org/10.1016/j.ijscr.2020.05.057.
[11] Noor M, Leyva A, Patacsil SJ, Patel M, Smith C. Hepatic angiosarcoma: a case presentation. Cureus. 2020;12(2). https://doi.org/10.7759/cureus.6848.
[12] Park JH, Kim JH. Pathologic differential diagnosis of metastatic carcinoma in the liver. Clinical and molecular hepatology. 2018;25(1):12-20. https://doi.org/10.3350/cmh.2018.0067.
[13] Choi JH. Histological and molecular evaluation of liver biopsies: A practical and updated review. International Journal of Molecular Sciences. 2025;26(16):7729. https://doi.org/10.3390/ijms26167729.
[14] Gopal P, Hu X, Robert ME, Zhang X. The evolving role of liver biopsy: Current applications and future prospects. Hepatology Communications. 2025;9(1):e0628. https://doi.org/10.1097/HC9.0000000000000628.
[15] Cao M, Zeng J, Wang J, Jiang J. A comprehensive analysis of percutaneous liver biopsy characteristics and pathological manifestations in a large patient cohort (2009–2024). BMC gastroenterology. 2025;25(1):67. https://doi.org/10.1186/s12876-025-03646-z.
[16] Alwahaibi N, Alwahaibi M. Liver biopsy in the modern era: from traditional techniques to artificial intelligence and multi-omics integration. Frontiers in Medicine. 2025;12:1678753. https://doi.org/10.3389/fmed.2025.1678753.
Volume 8, Issue 1
Winter 2026
Pages 19-24

  • Receive Date 18 January 2026
  • Revise Date 20 February 2026
  • Accept Date 28 February 2026
  • Publish Date 01 March 2026